Acute Care Hospital

Intensive Specialty Hospital (Long-Term Acute Care)

1800 Irving Place, Shreveport, LA 71101

Context that affects how to read this rating

Intensive Specialty Hospital (Long-Term Acute Care) is a Long-Term Care Hospital (LTCH) — a specialized facility for medically complex patients needing extended hospital stays, often involving prolonged mechanical ventilation, severe wounds, or complex IV antibiotic therapy. LTCHs do not receive a CMS Overall Hospital Star Rating because they are evaluated under the separate LTCH Quality Reporting Program (LTCH QRP). Headline LTCH outcomes emphasize ventilator liberation (weaning vent-dependent patients), spontaneous breathing trial compliance, discharge to community, and hospital-acquired infection rates.

Psychiatric Quality Measures (IPFQR)

Intensive Specialty Hospital (Long-Term Acute Care) is a psychiatric facility evaluated under the CMS Inpatient Psychiatric Facility Quality Reporting (IPFQR) program. Headline measures cover restraint and seclusion use, screening for antipsychotic-related metabolic side effects, substance-use and tobacco treatment, care transitions, follow-up after discharge, and readmissions.

Physical Restraint Use 0.0 hours per 1,000 patient-hours
National median: 0.1 hours Near national median

HBIPS-2 — hours of physical restraint use per 1,000 patient-hours. Lower is better; restraints carry physical and psychological risks.

Seclusion Use 0.0 hours per 1,000 patient-hours
National median: 0.0 hours Near national median

HBIPS-3 — hours of seclusion per 1,000 patient-hours. Lower is better; seclusion is used only when no other intervention works.

Metabolic Screening (SMD) 100.0 %
National median: 92.0 % Near national median

SMD — % of patients on antipsychotics screened for metabolic side effects (BMI, blood glucose, cholesterol). Antipsychotics raise metabolic-syndrome risk; screening catches it early.

Substance-Use Treatment Provided 3.0 %
National median: 74.0 % Worse than national median

SUB-2 — % of patients with alcohol/drug use referred for treatment during admission.

Substance-Use Treatment at Discharge 66.0 %
National median: 77.0 % Worse than national median

SUB-3 — % of patients with substance-use disorder offered or referred to treatment at discharge.

Tobacco-Use Treatment at Discharge 41.0 %
National median: 64.0 % Worse than national median

TOB-3 — % of patients using tobacco who received counseling and/or medication at discharge.

Transition Record Completed 36.0 %
National median: 77.0 % Worse than national median

TR-1 — % of discharges with a completed transition record including medications, follow-up plan, and crisis instructions.

Follow-up Within 7 Days 30.1 %
National median: 35.4 % Worse than national median

FAPH-7 — % of patients with a follow-up outpatient mental-health visit within 7 days of discharge. Predicts lower readmission risk.

Follow-up Within 30 Days 42.5 %
National median: 60.7 % Worse than national median

FAPH-30 — % of patients with a follow-up outpatient mental-health visit within 30 days of discharge.

30-Day Readmission Rate 21.4 %
National median: 19.1 % Worse than national median

READM-30-IPF — risk-standardized 30-day readmission rate. No Different Than the National Rate

Influenza Immunization 89.0 %
National median: 87.0 % Near national median

IMM-2 — % of patients given a flu vaccine during the inpatient stay.

Source: CMS Inpatient Psychiatric Facility Quality Reporting Program. Reporting period ending 12/31/2024.

Long-Term Care Hospital Quality Measures (LTCH QRP)

Intensive Specialty Hospital (Long-Term Acute Care) is evaluated under the CMS Long-Term Care Hospital Quality Reporting Program. Because LTCH patients typically need extended hospitalization for complex medical issues — often ventilator weaning — the headline measures emphasize ventilator liberation, breathing-trial compliance, and discharge to community, alongside the standard post-acute infection, function, and readmission set.

Ventilator Liberation 58.0%
National median: 60.3% n = 14 Near national median

Percentage of ventilator-dependent patients who were weaned off the ventilator during their stay. Higher is better — this is the headline LTCH outcome since many LTCH patients arrive on prolonged mechanical ventilation.

Spontaneous Breathing Trial (Component 1) 92.0%
National median: 99.0% n = 25 Worse than national median

Percentage of ventilator-dependent patients who received a daily spontaneous breathing trial assessment. Higher is better — SBTs are evidence-based ventilator weaning protocol.

Discharge to Community 21.8%
National median: 16.6% n = 1,055 Better than national median

Risk-standardized % of LTCH stays that ended at home. Higher is better.

Discharge Function Score 56.18
National median: 47.87 n = 677 Better than national median

Risk-adjusted Section GG (self-care + mobility) score at discharge. Higher is better.

Change in Mobility 5.99
National median: 6.26 Near national median

Risk-adjusted change in mobility scores during the LTCH stay. Higher is better — reflects mobility gains during rehabilitation.

Preventable Readmissions Post-Discharge (30 days) 24.15%
National median: 21.37% n = 232 Worse than national median

Risk-standardized % of LTCH stays followed by a preventable readmission to acute care within 30 days. Lower is better.

Pressure Ulcer / Skin Integrity 0.5%
National median: 0.0% n = 2 Better than national median

% of patients with no new or worsened pressure ulcers during the stay. Higher is better.

Falls With Major Injury 0.19
National median: 0.00 n = 3 Worse than national median

Rate of patient falls resulting in major injury (per 1,000 patient days). Lower is better.

CAUTI (Urinary Tract) Infection Ratio 0.18
National median: 0.58 95% CI: 0.05–0.51 Better than national median

Standardized Infection Ratio for catheter-associated UTIs — observed ÷ predicted. SIR < 1.0 is better than expected.

CLABSI (Central-Line Bloodstream) Infection Ratio 0.23
National median: 0.56 95% CI: 0.04–0.75 Better than national median

Standardized Infection Ratio for central-line bloodstream infections. CLABSI is a major LTCH concern given high central-line use. SIR < 1.0 is better than expected.

C. diff Infection Ratio 0.09
National median: 0.20 95% CI: 0.01–0.29 Better than national median

Standardized Infection Ratio for C. difficile. SIR < 1.0 is better than expected.

Drug Regimen Review With Follow-up 60.7%
National median: 70.5% n = 269 Worse than national median

% of patients whose drug regimen was reviewed with follow-up actions taken when issues were identified. Higher is better.

Transfer of Health Info to Provider 99.3%
National median: 95.6% n = 1,004 Near national median

% of discharges with a current reconciled medication list sent to the receiving provider. Higher is better.

Medicare Spending Per Beneficiary 0.93
National median: 0.99 Better than national median

Ratio of this LTCH's Medicare spending per beneficiary to the national average. 1.00 = matches national. Lower = more efficient.

Source: CMS Care Compare — LTCH Quality Reporting Program. National medians are computed across all reporting LTCHs in the current publication. Reporting period ending 09/30/2024.

Pricing & Costs

Facility Information

Facility type
Long-term
Ownership
Voluntary non-profit - Private
Emergency services
No

Nearby Hospitals

Acute Care Hospital

Specialists Hospital Shreveport

Shreveport, LA

Not rated · CMS Overall Hospital Quality Star Rating Not enough data to calculate a star rating. Individual quality measures may be available.
About this data

Quality and ratings data are sourced from the U.S. Centers for Medicare & Medicaid Services (CMS) Hospital Compare program. Star ratings are CMS's own calculation; CareRanks does not modify or re-weight them. Facility-level details (address, beds, ownership, teaching status) come from CMS provider files and the CMS Provider of Services file.

Pricing data, where shown, is drawn from the hospital's own Machine-Readable File (MRF) published under the federal Hospital Price Transparency Rule. See our methodology for the full update cadence and limitations.

Report an error on this page →